Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Buhl

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
Allergologie Select|May 11, 2026
Decoding allergy in vitro: Challenges and clinical use of humoral and cellular methodsBettina Wedi, Timo Buhl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2022
The flood of drug allergy casesTimo Buhl, Susann Forkel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 12, 2021
Customized immunology for precision medicineMichael P Schön, Timo Buhl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 12, 2021
Michael P Schön, Timo Buhl
Experimental Dermatology|April 10, 2016
Peeking into immunoregulatory effects of phototherapyTimo Buhl, Michael P Schön
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
48. Jahrestagung der "Arbeitsgemeinschaft Dermatologische Forschung" (ADF)Mario Fabri, Georg Stary, Timo Buhl
Journal of the American Academy of Dermatology|July 23, 2022
Glutaraldehyde sensitization does not explain reactivity to alkyl polyglucosides in personal care products: Results from review of a large contact allergy databaseJohannes Geier, Steffen Schubert, Timo Buhl
Frontiers in Neurology|November 23, 2017
Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity-Report of a Case and Review of the LiteratureJulian Zimmermann, Timo Buhl, Marcus Müller
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 13, 2022
Anxiety and limited understanding are the main reasons for refusing drug challenge testsSusann Forkel, Caroline Beutner, Timo Buhl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2022
Patienten lehnen empfohlene Arzneimittelprovokationen aus Angst und mangelndem Verständnis abSusann Forkel, Caroline Beutner, Timo Buhl
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Allergologie Select|May 11, 2026
Decoding allergy in vitro: Challenges and clinical use of humoral and cellular methodsBettina Wedi, Timo Buhl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2022
The flood of drug allergy casesTimo Buhl, Susann Forkel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 12, 2021
Customized immunology for precision medicineMichael P Schön, Timo Buhl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 12, 2021
Michael P Schön, Timo Buhl
Experimental Dermatology|April 10, 2016
Peeking into immunoregulatory effects of phototherapyTimo Buhl, Michael P Schön
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
48. Jahrestagung der "Arbeitsgemeinschaft Dermatologische Forschung" (ADF)Mario Fabri, Georg Stary, Timo Buhl
Journal of the American Academy of Dermatology|July 23, 2022
Glutaraldehyde sensitization does not explain reactivity to alkyl polyglucosides in personal care products: Results from review of a large contact allergy databaseJohannes Geier, Steffen Schubert, Timo Buhl
Frontiers in Neurology|November 23, 2017
Alopecia Universalis following Alemtuzumab Treatment in Multiple Sclerosis: A Barely Recognized Manifestation of Secondary Autoimmunity-Report of a Case and Review of the LiteratureJulian Zimmermann, Timo Buhl, Marcus Müller
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 13, 2022
Anxiety and limited understanding are the main reasons for refusing drug challenge testsSusann Forkel, Caroline Beutner, Timo Buhl
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2022
Patienten lehnen empfohlene Arzneimittelprovokationen aus Angst und mangelndem Verständnis abSusann Forkel, Caroline Beutner, Timo Buhl
Pageof 18